Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods
Adriana-Michelle Wolf Pérez, Nikolai Lorenzen, Michele Vendruscolo, et al.
Methods in molecular biology (2021), pp. 57-113
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV
Aubin Ramon, Montader Ali, Misha Atkinson, et al.
Nature Machine Intelligence (2024) Vol. 6, Iss. 1, pp. 74-91
Open Access | Times Cited: 24
Sequence-based prediction of pH-dependent protein solubility using CamSol
Marc Oeller, Ryan Kang, Rosie Bell, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Open Access | Times Cited: 28
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties
Hristo L. Svilenov, Paolo Arosio, Tim Menzen, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody
Jing Dai, Saeed Izadi, Jonathan Zarzar, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt
Aubin Ramon, Mingyang Ni, Olga Predeina, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Trends and Challenges in Bispecific Antibody Production
Mikhail S. Karbyshev, Irina Kalashnikova, Veronika Dubrovskaya, et al.
Journal of Chromatography A (2025), pp. 465722-465722
Closed Access
Fragment-based computational design of antibodies targeting structured epitopes
Mauricio Aguilar Rangel, A E Bedwell, Elisa Costanzi, et al.
Science Advances (2022) Vol. 8, Iss. 45
Open Access | Times Cited: 29
Automated optimisation of solubility and conformational stability of antibodies and proteins
Angelo Rosace, Anja Bennett, Marc Oeller, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles
Georgina Bethany Armstrong, Vidhi Shah, Paula Sanches, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2345-2357
Open Access | Times Cited: 4
Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics
Kuin Tian Pang, Yuansheng Yang, Wei Zhang, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108192-108192
Open Access | Times Cited: 10
Automated optimization of the solubility of a hyper-stable α-amylase
Montader Ali, Matthew Greenig, Marc Oeller, et al.
Open Biology (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 2
A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs
Itzel Condado Morales, Fabian Dingfelder, Isabel Waibel, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
ProtT5 and random forests-based viscosity prediction method for therapeutic mAbs
Xiaohu Hao, Long Fan
European Journal of Pharmaceutical Sciences (2024) Vol. 194, pp. 106705-106705
Open Access | Times Cited: 1
Enhancing viscosity control in antibody formulations: A framework for the biophysical screening of mutations targeting solvent-accessible hydrophobic and electrostatic patches
Georgina Bethany Armstrong, Vidhi Shah, Paula Sanches, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
Tushar Jain, Bianka Prinz, Alexander Marker, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Functional and structural analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in the MYB oncoproteins associated with human cancer
Shu Wen Lim, Kennet JunKai Tan, Osman Mohd Azuraidi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 13
Embedding Dynamics in Intrinsic Physicochemical Profiles of Market-Stage Antibody-Based Biotherapeutics
Giuseppe Licari, Kyle P. Martin, Maureen Crames, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 2, pp. 1096-1111
Open Access | Times Cited: 8
Multidimensional Protein Solubility Optimization with an Ultrahigh-Throughput Microfluidic Platform
Nadia A. Erkamp, Marc Oeller, Tomas Šneideris, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 12, pp. 5362-5368
Open Access | Times Cited: 4
AbNatiV: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering
Aubin Ramon, Montader Ali, Misha Atkinson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Fragment-based computational design of antibodies targeting structured epitopes
Mauricio Aguilar Rangel, A E Bedwell, Elisa Costanzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
AF4 and PEG Precipitation as Predictive Assays for Antibody Self-Association
Itzel Condado Morales, В А Соколова, Per‐Olof Wahlund, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 1323-1330
Closed Access | Times Cited: 2
Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions
Joshuaine Grant, Fei Hua, Joshua F. Apgar, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-Based Classifiers
Safa Haddad, Lalehan Oktay, İsmail Erol, et al.
ACS Omega (2023) Vol. 8, Iss. 43, pp. 40864-40877
Open Access | Times Cited: 2
A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications
Shuang Wang, Weijie Zhang, Baotian Yang, et al.
Antibody Therapeutics (2024) Vol. 7, Iss. 3, pp. 189-198
Open Access
Fit‐for‐purpose heterodivalent single‐domain antibody for gastrointestinal targeting of toxin B from Clostridium difficile
Everardo Remi Rodríguez-Rodríguez, Rune Thorbjørn Nordvang, Marcus Petersson, et al.
Protein Science (2024) Vol. 33, Iss. 7
Open Access
Page 1 - Next Page

Scroll to top